These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 321723)

  • 1. A clinical study of the use of human chorionic gonadotrophin in weight reduction.
    Miller R; Schneiderman LJ
    J Fam Pract; 1977 Mar; 4(3):445-8. PubMed ID: 321723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human chorionic gonadotropin (HCG) in the treatment of obesity: a critical assessment of the Simeons method.
    Greenway FL; Bray GA
    West J Med; 1977 Dec; 127(6):461-3. PubMed ID: 595585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human chorionic gonadotrophin and weight loss. A double-blind, placebo-controlled trial.
    Bosch B; Venter I; Stewart RI; Bertram SR
    S Afr Med J; 1990 Feb; 77(4):185-9. PubMed ID: 2405506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Risk-benefit analysis of a hCG-500 kcal reducing diet (cura romana) in females].
    Rabe T; Richter S; Kiesel L; Runnebaum B
    Geburtshilfe Frauenheilkd; 1987 May; 47(5):297-307. PubMed ID: 3609673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AN 448 Sandoz (Mazindol) in the treatment of obesity.
    Wallace AG
    Med J Aust; 1976 Mar; 1(11):343-5. PubMed ID: 775265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chorionic gonadotropin in weight control. A double-blind crossover study.
    Young RL; Fuchs RJ; Woltjen MJ
    JAMA; 1976 Nov; 236(22):2495-7. PubMed ID: 792477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of human chorionic gonadotrophin on weight loss, hunger, and feeling of well-being.
    Asher WL; Harper HW
    Am J Clin Nutr; 1973 Feb; 26(2):211-8. PubMed ID: 4574032
    [No Abstract]   [Full Text] [Related]  

  • 8. Ineffectiveness of human chorionic gonadotropin in weight reduction: a double-blind study.
    Stein MR; Julis RE; Peck CC; Hinshaw W; Sawicki JE; Deller JJ
    Am J Clin Nutr; 1976 Sep; 29(9):940-8. PubMed ID: 786001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Letter: Human chorionic gonadotrophin.
    Coote WJ
    Med J Aust; 1975 Jul; 2(4):151-2. PubMed ID: 1160751
    [No Abstract]   [Full Text] [Related]  

  • 10. [Weight reduction in obese diabetics: a double-blind study of diethylpropionate (author's transl)].
    Bratusch-Marrain P; Dudczak R; Waldhäusl W
    Wien Klin Wochenschr; 1979 Jun; 91(13):455-8. PubMed ID: 380178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human chorionic gonadotropin (HCG) treatment of obesity.
    Shetty KR; Kalkhoff RK
    Arch Intern Med; 1977 Feb; 137(2):151-5. PubMed ID: 836112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Is HCG therapy obesity warranted?].
    Berger M; Berchtold P; Jörgens V; Solbach HG; Zimmermann H
    Med Klin; 1980 Aug; 75(17):624-5. PubMed ID: 6997717
    [No Abstract]   [Full Text] [Related]  

  • 13. X-PERT: weight reduction with orlistat in obese subjects receiving a mildly or moderately reduced-energy diet: early response to treatment predicts weight maintenance.
    Toplak H; Ziegler O; Keller U; Hamann A; Godin C; Wittert G; Zanella MT; Zúñiga-Guajardo S; Van Gaal L
    Diabetes Obes Metab; 2005 Nov; 7(6):699-708. PubMed ID: 16219013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double blind evaluation of long acting diethylpropion hydrochloride in obese patients from a general practice.
    Carney DE; Tweddell ED
    Med J Aust; 1975 Jan; 1(1):13-5. PubMed ID: 1092973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human chorionic gonadotropin is of no value in the management of obesity.
    Birmingham CL; Smith KC
    Can Med Assoc J; 1983 May; 128(10):1156-7. PubMed ID: 6340811
    [No Abstract]   [Full Text] [Related]  

  • 16. Phentermine resin as an adjunct in medical weight reduction: a controlled, randomized, double-blind prospective study.
    Truant AP; Olon LP; Cobb S
    Curr Ther Res Clin Exp; 1972 Nov; 14(11):726-38. PubMed ID: 4629111
    [No Abstract]   [Full Text] [Related]  

  • 17. Bupropion SR enhances weight loss: a 48-week double-blind, placebo- controlled trial.
    Anderson JW; Greenway FL; Fujioka K; Gadde KM; McKenney J; O'Neil PM
    Obes Res; 2002 Jul; 10(7):633-41. PubMed ID: 12105285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of orlistat on weight regain and cardiovascular risk factors following a very-low-energy diet in abdominally obese patients: a 3-year randomized, placebo-controlled study.
    Richelsen B; Tonstad S; Rössner S; Toubro S; Niskanen L; Madsbad S; Mustajoki P; Rissanen A
    Diabetes Care; 2007 Jan; 30(1):27-32. PubMed ID: 17192328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of obesity with chorionic gonadotropins. Relations between obesity, dyslipidemia and arthero-arteriosclerosis].
    Vallini A; Fabbri F; Candi L; Davi D
    Minerva Med; 1976 Jul; 67(33):2113-32. PubMed ID: 951038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An evaluation of behavioral techniques reinforced with an anorectic drug in a double-blind weight loss study.
    Abramson R; Garg M; Cioffari A; Rotman PA
    J Clin Psychiatry; 1980 Jul; 41(7):234-7. PubMed ID: 6993445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.